Deka Bank Deutsche Girozentrale Xencor Inc Transaction History

Deka Bank Deutsche Girozentrale

  • $53.9 Billion
  • Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Xencor Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 31,800 shares of XNCR stock, worth $804,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,800
Previous 31,800 -0.0%
Holding current value
$804,540
Previous $603,000 4.81%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022
BUY
$26.68 - $41.63 $77,372 - $120,727
2,900 Added 10.03%
31,800 $874,000
Q4 2021

Feb 02, 2022
SELL
$33.67 - $43.44 $299,663 - $386,616
-8,900 Reduced 23.54%
28,900 $1.17 Million
Q4 2020

Mar 12, 2021
BUY
$36.63 - $47.63 $846,153 - $1.1 Million
23,100 Added 157.14%
37,800 $1.67 Million
Q3 2020

Oct 29, 2020
BUY
$30.09 - $43.02 $442,323 - $632,394
14,700 New
14,700 $569,000
Q4 2019

Feb 04, 2020
SELL
$32.75 - $41.43 $487,975 - $617,307
-14,900 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$33.73 - $46.27 $502,576 - $689,423
-14,900 Reduced 50.0%
14,900 $510,000
Q2 2019

Aug 01, 2019
BUY
$29.6 - $40.93 $343,360 - $474,788
11,600 Added 63.74%
29,800 $1.21 Million
Q1 2019

May 10, 2019
BUY
$27.85 - $38.09 $91,905 - $125,697
3,300 Added 22.15%
18,200 $765,000
Q4 2018

Feb 12, 2019
SELL
$32.39 - $42.05 $106,887 - $138,765
-3,300 Reduced 18.13%
14,900 $514,000
Q3 2018

Nov 09, 2018
SELL
$35.69 - $47.65 $17,845 - $23,825
-500 Reduced 2.67%
18,200 $0
Q1 2018

May 03, 2018
SELL
$21.18 - $33.78 $114,372 - $182,412
-5,400 Reduced 22.41%
18,700 $546,000
Q3 2017

Nov 06, 2017
BUY
$19.61 - $23.35 $472,601 - $562,735
24,100
24,100 $506,000

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.51B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email